11 nominees · 6 ballot items.
Elect 11 directors; advisory approval of executive compensation; ratify independent auditor; approve two amendments to CMS articles (increase authorized common shares and allow shareholders to call special meetings); and vote on a shareholder proposal to permit shareholders to act by written consent.
Election of 11 director nominees to serve until the next annual meeting.
Non-binding advisory vote to approve the compensation of the named executive officers as disclosed in the proxy statement.
Ratification of the Audit Committee’s selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026.
Amend CMS Restated Articles to increase authorized common shares from 350 million to 700 million.
The Board is asking shareholders to approve an amendment to the Restated Articles of Incorporation to increase authorized Common Stock from 350 million to 700 million shares, expanding total authorized capital stock to 710 million shares. Management frames the increase as a prudential measure to provide flexibility for future corporate needs such as share issuances for employee plans, equity financings, acquisitions, stock splits, stock dividends, and other general corporate purposes. The disclosure notes that as of March 10, 2026 approximately 308 million shares were outstanding and roughly 42 million were reserved for conversions, employee plans, and an equity distribution agreement, leaving only about 2 million shares available. The Board states there is no present plan to issue additional shares and does not propose the amendment as an anti-takeover device, though notes that additional shares could potentially make control transactions more difficult in some circumstances. Approval requires a majority of outstanding CMS common shares and, if approved, the amendment will be filed with the Michigan Secretary of State and become effective upon filing. The Board unanimously recommends a FOR vote, emphasizing flexibility and corporate preparedness while disclaiming any immediate intent to use the shares for dilutionary or defensive measures.
Amend Articles to permit shareholders holding at least 10% of voting shares to call a special meeting, with procedural details to be set in bylaws.
The Board proposes to amend Article V of the Articles of Incorporation to permit shareholders holding at least 10% of voting shares to call a special meeting, with the procedural mechanics to be established in the bylaws. Management argues this change enhances shareholder rights and responsiveness by providing a structured pathway for minority shareholders to convene special meetings while maintaining safeguards through a 10% ownership threshold and bylaws-based procedural limits. The Board considered governance trends and a prior non-binding shareholder vote on special meeting rights; it concluded that the benefits of providing an orderly mechanism for shareholder-initiated meetings outweigh potential risks. The amendment requires a majority of outstanding shares to approve and will become effective upon filing with the Michigan Secretary of State. The Board recommends a FOR vote underscoring improved shareholder engagement and that customary procedural requirements will be adopted in the bylaws.
A shareholder proposal requesting that the Board permit shareholders to act by written consent to take corporate actions without a meeting.
The shareholder proposal, submitted by John Chevedden, requests that the Board permit shareholders to act by written consent — allowing shareholders holding the minimum votes required to authorize action at a hypothetical meeting of all shareholders to take corporate actions without convening a meeting. The proponent argues written consent provides a timely mechanism for shareholder action between meetings, could improve accountability when company performance lags, and cites perceived stock underperformance and operational risks as rationale. Management recommends voting against the proposal, arguing that written consent can be misused, may allow small or transient holders to force actions without broad shareholder deliberation, and duplicates the right to call special meetings (for which Proposal 5 would provide a 10% threshold). The Board emphasizes existing governance safeguards, shareholder engagement channels and that special meetings preserve transparency and participation. The proxy includes the proponent’s verbatim supporting statement and the Board’s verbatim opposition statement. The Board recommends AGAINST the shareholder proposal, while the proponent seeks FOR support.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.43% | 19,877,297 | $1.5B |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.08% | 18,793,345 | $1.5B |
| 3 | STATE STREET CORP | 5.86% | 18,099,033 | $1.4B |
| 4 | BlackRock, Inc. | 4.81% | 14,857,489 | $1.2B |
| 5 | JPMORGAN CHASE CO | 4.03% | 12,459,135 | $962M |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.44% | 7,531,729 | $582M |
| 7 | BlackRock, Inc. | 2.27% | 6,997,231 | $543M |
| 8 | DEUTSCHE BANK AG\ | 2.14% | 6,598,617 | $512M |
| 9 | VICTORY CAPITAL MANAGEMENT INC | 2.12% | 6,564,462 | $509M |
| 10 | WELLINGTON MANAGEMENT GROUP LLP | 1.87% | 5,772,282 | $448M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.